These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 18931881)
21. Novel peptides from the RAS-p21 and p53 proteins for the treatment of cancer. Bowne WB; Michl J; Bluth MH; Zenilman ME; Pincus MR Cancer Ther; 2007; 5B():331-344. PubMed ID: 18007958 [TBL] [Abstract][Full Text] [Related]
22. Ex vivo Efficacy of Anti-Cancer Drug PNC-27 in the Treatment of Patient-Derived Epithelial Ovarian Cancer. Sarafraz-Yazdi E; Gorelick C; Wagreich AR; Salame G; Angert M; Gartman CH; Gupta V; Bowne WB; Lee YC; Abulafia O; Pincus MR; Michl J Ann Clin Lab Sci; 2015; 45(6):650-8. PubMed ID: 26663795 [TBL] [Abstract][Full Text] [Related]
24. Trans-membrane peptide therapy for malignant glioma by use of a peptide derived from the MDM2 binding site of p53. Yamada S; Kanno H; Kawahara N J Neurooncol; 2012 Aug; 109(1):7-14. PubMed ID: 22528789 [TBL] [Abstract][Full Text] [Related]
25. Shin H; Cha HJ; Na K; Lee MJ; Cho JY; Kim CY; Kim EK; Kang CM; Kim H; Paik YK Cancer Res; 2018 Mar; 78(5):1214-1224. PubMed ID: 29301793 [TBL] [Abstract][Full Text] [Related]
26. The Roles of ROS and Caspases in TRAIL-Induced Apoptosis and Necroptosis in Human Pancreatic Cancer Cells. Zhang M; Harashima N; Moritani T; Huang W; Harada M PLoS One; 2015; 10(5):e0127386. PubMed ID: 26000607 [TBL] [Abstract][Full Text] [Related]
27. Flavopiridol induces p53 via initial inhibition of Mdm2 and p21 and, independently of p53, sensitizes apoptosis-reluctant cells to tumor necrosis factor. Demidenko ZN; Blagosklonny MV Cancer Res; 2004 May; 64(10):3653-60. PubMed ID: 15150125 [TBL] [Abstract][Full Text] [Related]
28. A small synthetic peptide, which inhibits the p53-hdm2 interaction, stimulates the p53 pathway in tumour cell lines. Chène P; Fuchs J; Bohn J; García-Echeverría C; Furet P; Fabbro D J Mol Biol; 2000 May; 299(1):245-53. PubMed ID: 10860736 [TBL] [Abstract][Full Text] [Related]
29. [Expression of proteins in p53 (p14ARF-mdm2-p53-p21WAF/CIP1) pathway and their significance in exocrine pancreatic carcinoma]. Yu GZ; Zhu MH; Ni CR; Li FM; Zheng JM; Gong ZJ Zhonghua Bing Li Xue Za Zhi; 2004 Apr; 33(2):130-4. PubMed ID: 15132849 [TBL] [Abstract][Full Text] [Related]
30. Expression of p53 synergistically augments caspases-mediated apoptosis induced by replication-competent adenoviruses in pancreatic carcinoma cells. Takei Y; Okamoto S; Kawamura K; Jiang Y; Morinaga T; Shingyoji M; Sekine I; Kubo S; Tada Y; Tatsumi K; Shimada H; Hiroshima K; Yamaguchi N; Tagawa M Cancer Gene Ther; 2015 Sep; 22(9):445-53. PubMed ID: 26251031 [TBL] [Abstract][Full Text] [Related]
31. Toxico-pharmacological evaluations of the small-molecule LQFM166: Inducer of apoptosis and MDM2 antagonist. Dos Santos TRM; Garcia da Silva AC; de Carvalho FS; Sanz G; Vaz BG; Lião LM; Menegatti R; Valadares MC Chem Biol Interact; 2018 Sep; 293():20-27. PubMed ID: 30057354 [TBL] [Abstract][Full Text] [Related]
32. Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells. Hastak K; Gupta S; Ahmad N; Agarwal MK; Agarwal ML; Mukhtar H Oncogene; 2003 Jul; 22(31):4851-9. PubMed ID: 12894226 [TBL] [Abstract][Full Text] [Related]
33. Implication of p53 in growth arrest and apoptosis induced by the synthetic retinoid CD437 in human lung cancer cells. Sun SY; Yue P; Wu GS; El-Deiry WS; Shroot B; Hong WK; Lotan R Cancer Res; 1999 Jun; 59(12):2829-33. PubMed ID: 10383141 [TBL] [Abstract][Full Text] [Related]
34. Synergy between Paclitaxel and Anti-Cancer Peptide PNC-27 in the Treatment of Ovarian Cancer. Alagkiozidis I; Gorelick C; Shah T; Chen YA; Gupta V; Stefanov D; Amarnani A; Lee YC; Abulafia O; Sarafraz-Yazdi E; Michl J Ann Clin Lab Sci; 2017 May; 47(3):271-281. PubMed ID: 28667027 [TBL] [Abstract][Full Text] [Related]
35. Induction of p21 and nuclear accumulation of TAp73alpha and c-abl during apoptosis of cisplatin-treated primary pancreatic acinar cells. Sphyris N; Morris RG; Harrison DJ Int J Oncol; 2004 Dec; 25(6):1661-70. PubMed ID: 15547703 [TBL] [Abstract][Full Text] [Related]
36. Effector mechanisms of norcantharidin-induced mitotic arrest and apoptosis in human hepatoma cells. Chen YN; Chen JC; Yin SC; Wang GS; Tsauer W; Hsu SF; Hsu SL Int J Cancer; 2002 Jul; 100(2):158-65. PubMed ID: 12115564 [TBL] [Abstract][Full Text] [Related]
37. Butyrate sensitizes human colon cancer cells to TRAIL-mediated apoptosis. Hernandez A; Thomas R; Smith F; Sandberg J; Kim S; Chung DH; Evers BM Surgery; 2001 Aug; 130(2):265-72. PubMed ID: 11490359 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of pancreatic cancer cell growth and induction of apoptosis with novel therapies directed against protein kinase A. Farrow B; Rychahou P; Murillo C; O'connor KL; Iwamura T; Evers BM Surgery; 2003 Aug; 134(2):197-205. PubMed ID: 12947318 [TBL] [Abstract][Full Text] [Related]
39. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells. Jiang XH; Wong BC; Lin MC; Zhu GH; Kung HF; Jiang SH; Yang D; Lam SK Oncogene; 2001 Nov; 20(55):8009-18. PubMed ID: 11753684 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of the p53-MDM2 interaction by adenovirus delivery of ribosomal protein L23 stabilizes p53 and induces cell cycle arrest and apoptosis in gastric cancer. Zhang Y; Shi Y; Li X; Du W; Luo G; Gou Y; Wang X; Guo X; Liu J; Ding J; Wu K; Fan D J Gene Med; 2010 Feb; 12(2):147-56. PubMed ID: 20020415 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]